Articles by Amy Nordrum

Amy Nordrum is a science writer at International Business Times. In the past, her work has been featured by Scientific American, Smithsonian Magazine, IEEE Spectrum and The Atlantic. Amy holds a master's degree from the Science, Health and Environmental Reporting Program at New York University. 

Trader

Wanted: A Smarter Economic Model

What if ecologists who study food webs and epidemiologists who study diseases could help central bankers predict the next financial crisis?
FDA Scientist

The FDA’s Chronic Recruitment Problem

An infectious-disease expert says the FDA needs to work harder to recruit and keep young scientists, convincing them the agency does not stifle good work.
soliris-vial

The World’s Most Expensive Drug

Soliris, which treats a rare blood condition, costs $440,000 a year. Many of those who don't need it resent paying higher insurance premiums to subsidize it for others.
Ajob1

Obama Takes A Bow As Jobless Rate Falls

January marked "the first time the unemployment rate has dipped below 5 percent in almost eight years,” the president said. “Americans are working.”
GettyImages-508359708

How To Price Drugs In Post-Shkreli Era

As Congress grills pharma executives — including former Turing CEO Martin Shkreli — on how they set prices for prescription drugs, here are some potential fixes.
horizontal

How To Stem Heroin Overdoses In America

The growing heroin problem has opened up a big market for a nasal spray known as Narcan, a drug that reverses overdoses and will be available in 35 states without a prescription next month.

Pages

Trade War: How to Invest in Turbulent Times

If you are considering investing, you need to familiarize yourself with the major political developments occurring now in the world, because stock markets are as dependent on politics as they are...